About PTRL Europe
PTRL Europe is a company based in Ulm (Germany) founded in 1992 by Luis Octavio Ruzo was acquired by Evans Analytical Group in April 2012. The company has 51 employees as of December 31, 2021. PTRL Europe operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
- Headquarter Ulm, Germany
- Employees 51 as on 31 Dec, 2021
- Founders Luis Octavio Ruzo
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Eurofins Agroscience Services Eag Laboratories Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
51
as on Dec 31, 2021
-
Acquired by
Evans Analytical Group
(Apr 10, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PTRL Europe
Detailed funding history for PTRL Europe
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in PTRL Europe
PTRL Europe has secured backing from 1 investor. Prominent investors backing the company include Evans Analytical Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
|
Locked | Locked | Locked |
Investor details for PTRL Europe
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PTRL Europe
Investment portfolio details for PTRL Europe
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PTRL Europe
Detailed financials for PTRL Europe
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ptrl Europe Comparisons
Peer comparison for PTRL Europe
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PTRL Europe
PTRL Europe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to pharmaceutical clients worldwide.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
Detailed competitors of PTRL Europe
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ptrl Europe
Complete news archive for PTRL Europe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PTRL Europe
PTRL Europe was founded in 1992.
PTRL Europe is headquartered in Ulm, Germany. It is registered at Ulm, Baden-wurttemberg, Germany.
As of Dec 31, 2021, the latest employee count at PTRL Europe is 51.
PTRL Europe was established in 1992 in Ulm, Germany, as a contract research organization serving the pharmaceutical sector. Drug development processes are supported through specialized research services, including preclinical studies and regulatory compliance. Operations are centered in Europe, with a focus on collaborative partnerships for innovative therapeutic solutions. The company is co-founded by Luis Octavio Ruzo, emphasizing expertise in biopharmaceutical advancements.
PTRL Europe's top competitors include Evotec, Crown Bioscience and NIH.
PTRL Europe has 1 investor. Key investors include Evans Analytical Group.